SCHEMBL4628874

SCHEMBL4628874

O=C(OCc1ccccc1)ON1CCC(N2CCNCC2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.43
HPGD P15428 1/20 0.43
KMT2A Q03164 1/20 0.43
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 2/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
HTR2C P28335 2/20 0.41
CYP2C19 P33261 1/20 0.41
SIGMAR1 Q99720 6/20 0.41
TMEM97 Q5BJF2 5/20 0.41
HTR1A P08908 2/20 0.41
HRH2 P25021 2/20 0.41
HRH1 P35367 2/20 0.41
HRH3 Q9Y5N1 2/20 0.41
ADRA2C P18825 1/20 0.41
CHRM4 P08173 1/20 0.39
CHRM5 P08912 1/20 0.39
ADRA2A P08913 1/20 0.39
ADRA2B P18089 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4720112 0.90 KDM4E (0.45) SMN1; SMN2KDM4EALDH1A1NPC1RAB9A
SCHEMBL690539 0.87 HTR2C (0.46) SMN1; SMN2KMT2AALDH1A1NPC1RAB9A
SCHEMBL1206723 0.82 SMN1; SMN2 (0.64) SMN1; SMN2KMT2ANPC1RAB9AHTR2C
SCHEMBL4629722 0.79 SMN1; SMN2 (0.41) SMN1; SMN2KDM4EALDH1A1NPC1RAB9A
SCHEMBL4707711 0.78 SMN1; SMN2 (0.53) SMN1; SMN2KMT2AALDH1A1NPC1RAB9A
SCHEMBL31085865 0.78 SMN1; SMN2 (0.57) SMN1; SMN2KMT2ANPC1RAB9AHTR2C
SCHEMBL29260212 0.78 SMN1; SMN2 (0.57) SMN1; SMN2KMT2ANPC1RAB9AHTR2C
SCHEMBL5198237 0.77 SMN1; SMN2 (0.46) SMN1; SMN2KMT2AALDH1A1NPC1RAB9A
SCHEMBL28636570 0.76 SMN1; SMN2 (0.54) SMN1; SMN2KMT2ANPC1RAB9AHTR2C
SCHEMBL519379 0.75 SMN1; SMN2 (0.60) SMN1; SMN2KMT2AKDM4EALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1917256-A2 SELECTED CGRP ANTAGONISTS, METHODS FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS Boehringer Ingelheim International GmbH (DE) 2008-05-07 EP disclosed
WO-2007020261-A2 SELECTED CGRP ANTAGONISTS, METHODS FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-02-22 WO disclosed